1. Zhang, Chengfei, Wang, Xiaoming, Fang, Dan, Hui, Kam Man, Xia, Hongping. 2021. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. In Theranostics, 11, 2108-2122. doi:10.7150/thno.48112. https://pubmed.ncbi.nlm.nih.gov/33500714/
2. Bazot, Quentin, Paschos, Kostas, Allday, Martin J. 2018. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. In Journal of virology, 92, . doi:10.1128/JVI.01918-17. https://pubmed.ncbi.nlm.nih.gov/29367247/
3. Ramoz, Nicolas, Cai, Guiqing, Reichert, Jennifer G, Silverman, Jeremy M, Buxbaum, Joseph D. . An analysis of candidate autism loci on chromosome 2q24-q33: evidence for association to the STK39 gene. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 147B, 1152-8. doi:10.1002/ajmg.b.30739. https://pubmed.ncbi.nlm.nih.gov/18348195/
4. Xi, Bo, Chen, Man, Chandak, Giriraj R, He, Juan, Mou, Si-Hua. 2013. STK39 polymorphism is associated with essential hypertension: a systematic review and meta-analysis. In PloS one, 8, e59584. doi:10.1371/journal.pone.0059584. https://pubmed.ncbi.nlm.nih.gov/23527223/
5. Xu, Qing, Liu, Fei, Wu, Zhenru, Zhou, Yongjie, Shi, Yujun. 2024. Suppression of STK39 weakens the MASLD/MASH process by protecting the intestinal barrier. In Bioscience trends, 18, 289-302. doi:10.5582/bst.2024.01097. https://pubmed.ncbi.nlm.nih.gov/38925962/
6. Qiu, Zhaoping, Dong, Bo, Guo, Weijie, Evers, B Mark, Wu, Yadi. 2021. STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation. In Theranostics, 11, 7658-7670. doi:10.7150/thno.62406. https://pubmed.ncbi.nlm.nih.gov/34335956/
智鼠故事 
